Financial reports
ARS
2023 FY
Annual report to shareholders
23 Apr 24
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
18 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
15 Apr 24
8-K
Other Events
7 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
5 Mar 24
8-K
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
5 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
6 Feb 24
8-K
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
14 Nov 23
8-K
Entry into a Material Definitive Agreement
9 Nov 23
8-K
Entry into a Material Definitive Agreement
3 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Sep 23
8-K
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update
10 Aug 23
Registration and prospectus
424B4
Prospectus supplement with pricing info
12 Apr 24
S-1/A
IPO registration (amended)
9 Apr 24
S-1/A
IPO registration (amended)
29 Mar 24
S-1
IPO registration
20 Mar 24
S-3
Shelf registration
22 Nov 23
424B4
Prospectus supplement with pricing info
3 Aug 23
S-1/A
IPO registration (amended)
1 Aug 23
S-1/A
IPO registration (amended)
14 Jul 23
S-1
IPO registration
30 Jun 23
S-8
Registration of securities for employees
7 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
23 Apr 24
DEF 14A
Definitive proxy
23 Apr 24
DEFR14A
Revised proxy
30 Jan 24
DEFR14A
Revised proxy
16 Jan 24
DEF 14A
Definitive proxy
22 Dec 23
PRE 14A
Preliminary proxy
12 Dec 23
DEFA14A
Additional proxy soliciting materials
19 Apr 23
DEF 14A
Definitive proxy
18 Apr 23
DEF 14A
Definitive proxy
27 Apr 22
DEFA14A
Additional proxy soliciting materials
21 Jun 21
Other
EFFECT
Notice of effectiveness
11 Apr 24
EFFECT
Notice of effectiveness
1 Dec 23
CORRESP
Correspondence with SEC
29 Nov 23
UPLOAD
Letter from SEC
29 Nov 23
EFFECT
Notice of effectiveness
2 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
28 Jul 23
CORRESP
Correspondence with SEC
26 Jul 23